Condition
Melancholia
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 2 (2)
P 4 (2)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03288675Not ApplicableCompleted
Stepped Care AiTBS 2 Depression Study (Ghent)
NCT04160377Phase 2Unknown
A Clinical Trial of Fluvoxamine for Melancholia
NCT02989727Phase 4Completed
Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine
NCT01548937Phase 2CompletedPrimary
Serotonin Transporter Density in Late-life Depression With and Without Dementia
NCT00000378Phase 4Completed
Antidepressant Treatment of Melancholia in Late Life
Showing all 5 trials